An insider look at Trebla over the months
MOST RECENT POSTS FROM THE TREBLA TEAM TO YOU
Here at Trebla we love to keep our clients updated and involved.
It is important to us that our clients are aware of changes in the pharmaceutical space and opportunities that may arise. That’s why we decided to create our monthly newsletter, The Trebla Times, where all that and more can be found.
Make sure to check it out!
May 2026
This month, the market kept building on the momentum we started seeing earlier this year. Layoffs stayed surprisingly quiet, and competition for talent continues to ramp up as companies move faster, and candidates gain leverage.
April 2026
After a quieter start to the year, the market feels noticeably different: more roles opening, more companies moving with urgency, and more candidates juggling multiple offers. Dare we say, the market is back!
March 2026
March brought the momentum the market has been building toward. After a slow start to the year, biotech is finally starting to defrost. M&A activity is picking up, hiring remains active across clinical and regulatory functions, and investors are re-engaging.
At Trebla, we felt that shift firsthand with new partnerships, continued growth, and a strong pipeline of talent.